0.6124USD+1.44%Mkt Cap: 2.76M USDP/E: —Last update: 2026-06-01
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is O…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap2.76M USD
Enterprise Value-3.34M USD
Revenue (TTM)—
Gross Profit-2.39M USD
Net Income (TTM)-9.84M USD
Revenue/Share—
Last Price0.6124 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS6840235005
Valuation
P/E (Trailing)—
P/E (Forward)-0.06
PEG-8.96
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.43
EPS (TTM)-4.95
EPS (Forward)-10.80
52W Range
0.50001% of range9.600
52W High9.600 USD
52W Low0.5000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-118.85%
ROA-97.76%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.25M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-215.83%
Net Debt-6.05M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.03
Current Ratio5.73
Quick Ratio4.67
Book Value/Sh1.413 USD
Cash/Share1.354 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 22, 2018
Splits
Last Split1:30
Split DateJun 3, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.51M
Float4.41M
Insiders1.93%
Institutions5.79%
Short Interest
Short Ratio11.4d
Short % Float14.57%
Short % Out.14.55%
Shares Short656.58K
Short (prev mo.)703.47K
Technical
SMA 500.6186 (-1.0%)
SMA 2000.9166 (-33.2%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)55.54K
Avg Vol (10d)48.98K
Technical Indicators
RSI (14)49.3
MACD-0.0108
MACD Signal-0.0161
MACD Hist.+0.0053
BB Upper0.6365 USD
BB Middle0.5946 USD
BB Lower0.5528 USD
BB Width14.07%
ATR (14)0.0391 USD
Vol Ratio (20d)0.49x